Inventor · disambiguated record
Rafael Maldonado
Also filed as: MALDONADO RAFAEL
5 granted patents·3 pending applications·4 citations·filing 2012–2021
69Inventor score
Top patents by PatentIndex Score
8 records- 0175US10040816B2Antagonists of CB1 receptorINST NAT SANTE RECH MED·Filed 2016·Granted Aug 7, 2018·3 cites·18 claims
- 0265US12150927B2Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disordersGW RES LTD·Filed 2020·Granted Nov 26, 2024·0 cites·6 claims
- 0363US2022153776A1Antagonists of cb1 receptorINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0460US10150793B2Antagonists of CB1 receptorPIAZZA PIER VINCENZO·Filed 2012·Granted Dec 11, 2018·1 cites·2 claims
- 0559US10898462B2Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disordersGW RES LTD·Filed 2017·Granted Jan 26, 2021·0 cites·18 claims
- 0658US11752111B2Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophreniaGW RES LTD·Filed 2017·Granted Sep 12, 2023·0 cites·18 claims
- 0748US2019071465A1Antagonists of cb1 receptorPIAZZA PIER VINCENZO·Filed 2018·Application pending·0 cites
- 0846US2019070128A1Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophreniaGW RES LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rafael Maldonado files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →